Bio-Rad Laboratories | BIO - Selling And Administration Expenses


Bio-Rad Laboratories reported $212.4M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.6B 330M Jun/2026
Agilent USD 465M 11M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 212.4M 8.6M Mar/2026
Bruker USD 238.9M 3.2M Jun/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Danaher USD 2.07B 212M Jun/2026
General Electric Aerospace USD 1.13B 47M Jun/2026
Illumina USD 273M 1000K Jun/2026
IQVIA Holdings USD 574M 72M Jun/2026
Laboratory Of America USD 577.2M 26.2M Jun/2026
Merck USD 2.67B 180M Mar/2026
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quest Diagnostics USD 529M 25M Jun/2026
Repligen USD 76.62M 82K Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Siemens EUR 3.56B 45M Mar/2026
Standard Biotools USD 18.61M 2.94M Mar/2026
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
Tosoh JPY 43.44B 1.04B Jun/2026
Waters USD 405M 11M Jun/2026